12:00 AM
 | 
Sep 24, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

AVI-7288 regulatory update

FDA granted Fast Track designation for Sarepta's AVI-7288 to treat Marburg virus infection and AVI-7537 to treat Ebola virus infection. Sarepta is developing the compounds, which are single oligomer nucleic acid analog based on morpholino-modified phosphorodiamidate oligomers (PMO) antisense chemistry, under...

Read the full 195 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >